Altered xanthine oxidase and N-acetyltransferase activity in obese children

作者：Chiney Manoj S; Schwarzenberg Sarah J; Johnson L'Aurelle A^*

来源：British Journal of Clinical Pharmacology, 2011, 72(1): 109-115.

DOI：10.1111/j.1365-2125.2011.03959.x

• caffeine
• drug metabolism
• obesity
• paediatric

AIMS
It is well established that oxidative and conjugative enzyme activity differs between obese and healthy-weight adults. However, the effect of obesity on drug metabolism in children has not been studied extensively. This study examined whether obese and healthy-weight children vary with respect to oxidative enzyme activity of CYP1A2, xanthine oxidase (XO) and conjugative enzyme activity of N-acetyltransferase 2 (NAT2).
METHODS
In vivo CYP1A2, XO and NAT2 activity was assessed in obese (n = 9) and lean (n = 16) children between the ages of 6-10 years using caffeine (118.3 ml Coca Cola (R)) as probe. Urine samples were collected in 2-h increments over 8 h. Caffeine and metabolites were measured using LC/MS, and urinary metabolic ratios were determined based on reported methods.
RESULTS
Sixteen healthy-weight and nine obese children were evaluated. XO activity was elevated in paediatric obese volunteers compared with non-obese paediatric volunteers (XO metabolic ratio of 0.7 +/- 0.06 vs. 0.6 +/- 0.06, respectively, 95% CI 0.046, 0.154, P < 0.001). NAT2 activity was fivefold higher in the obese (1 +/- 0.4) as compared with non-obese children (0.2 +/- 0.1), 95% CI 0.26, 1.34, P < 0.05. However, no difference was observed in CYP1A2 activity between the groups (95% CI-2.72, 0.12, P > 0.05).
CONCLUSIONS
This study provides evidence that obese children have elevated XO and NAT2 enzyme activity when compared with healthy-weight controls. Further studies are needed to determine how this may impact the efficacy of therapeutic agents that may undergo metabolism by these enzymes.

• 出版日期2011-7